Peter W. Mason mainly focuses on Virology, Virus, Flavivirus, Viral replication and Microbiology. His primary area of study in Virology is in the field of Neutralizing antibody. Virus connects with themes related to Virulence in his study.
His Flavivirus research includes themes of Interferon, Dengue virus and Recombinant virus. His work deals with themes such as Vaccinia, Poxviridae and Orthopoxvirus, which intersect with Recombinant virus. His studies deal with areas such as Coding region, Molecular biology, RNA interference, Host factor and Picornavirus as well as Viral replication.
Peter W. Mason focuses on Virology, Virus, Flavivirus, Antibody and Foot-and-mouth disease virus. Specifically, his work in Virology is concerned with the study of Viral replication. The Virus study combines topics in areas such as Molecular biology and Transfection.
His work carried out in the field of Flavivirus brings together such families of science as Interferon, Flaviviridae and Dengue virus, Dengue fever. His Foot-and-mouth disease virus study combines topics in areas such as Complementary DNA and Foot-and-mouth disease. The concepts of his Recombinant virus study are interwoven with issues in Vaccinia, Poxviridae, Orthopoxvirus and Humoral immunity.
Peter W. Mason mainly investigates Virology, Virus, Antibody, Immune system and Immunogenicity. His study in Virology is interdisciplinary in nature, drawing from both Adjuvant and Antigen. His Virus study integrates concerns from other disciplines, such as Reverse genetics and Genome.
The Monoclonal antibody, Epitope and Memory B cell research Peter W. Mason does as part of his general Antibody study is frequently linked to other disciplines of science, such as TLR3, therefore creating a link between diverse domains of science. His Immune system research incorporates themes from RNA, Messenger RNA and Nucleic acid. His Foot-and-mouth disease virus study combines topics from a wide range of disciplines, such as Cell culture, Recombinant virus and Active site.
Virology, Antibody, Virus, Immune system and Immunogenicity are his primary areas of study. His biological study spans a wide range of topics, including Epitope, Antigen and Messenger RNA. His study looks at the relationship between Epitope and topics such as Glycoprotein complex, which overlap with Neutralizing antibody.
His work in Antigen covers topics such as Human cytomegalovirus which are related to areas like Cytotoxic T cell, Viral entry, Glycoprotein, Pentamer and Alphavirus. His work deals with themes such as RNA, Cell, Nucleic acid and Electroporation, which intersect with Messenger RNA. His Hemagglutinin research is multidisciplinary, relying on both Neuraminidase, Synthetic vaccine, Influenza vaccine, Microbiology and Influenza A virus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
RNA interference screen for human genes associated with West Nile virus infection.
Manoj N Krishnan;Aylwin Ng;Bindu Sukumaran;Felicia D Gilfoy.
Nonviral delivery of self-amplifying RNA vaccines
Andrew J. Geall;Ayush Verma;Gillis R. Otten;Christine A. Shaw.
Proceedings of the National Academy of Sciences of the United States of America (2012)
Antibodies to the vitronectin receptor (integrin alpha V beta 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells
A Berinstein;M Roivainen;T Hovi;P W Mason.
Journal of Virology (1995)
Molecular basis of pathogenesis of FMDV.
Peter W Mason;Marvin J Grubman;Barry Baxt.
Virus Research (2003)
Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle.
Daniel Sa-Carvalho;Elizabeth Rieder;Barry Baxt;Renato Rodarte.
Journal of Virology (1997)
RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
Peter W. Mason;Elizabeth Rieder;Barry Baxt.
Proceedings of the National Academy of Sciences of the United States of America (1994)
Yellow Fever/Japanese Encephalitis Chimeric Viruses: Construction and Biological Properties
Thomas J. Chambers;Ann Nestorowicz;Peter W. Mason;Charles M. Rice.
Journal of Virology (1999)
Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells
Peter W. Mason.
Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor.
Sherry Neff;Daniel Sá-Carvalho;Elizabeth Rieder;Peter W. Mason.
Journal of Virology (1998)
Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.
Peter W. Mason;Steven Pincus;Maurille J. Fournier;Thomas L. Mason.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: